Soc. Generale Knock-Out GLPGF/ DE000SV3MAM6 /
| 1/9/2025 9:05:49 AM | Chg.+0.45 | Bid10:00:35 PM | Ask10:00:35 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 2.26EUR | +24.86% | - Bid Size: - |
- Ask Size: - |
Galapagos N.V. | 48.7656 EUR | 12/31/2078 | Put |
Newsfile Corp
10/25/2024
Trundless Expands Focus on Ecuador as a Top 2024 Travel Spot for Nature and Culture
Newsfile Corp
9/6/2024
Metropolitan Touring Achieves Sustainability Benchmark with Carbon-Neutral Commitment
GlobeNewswire
8/23/2024
Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, G...
GlobeNewswire
8/1/2024
Galapagos reports half-year 2024 financial results and provides second quarter business update
GlobeNewswire
6/14/2024
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at...
GlobeNewswire
5/30/2024
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively licens...
GlobeNewswire
5/15/2024
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...
GlobeNewswire
4/30/2024
Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and E...
GlobeNewswire
4/4/2024
Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire
3/28/2024
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
GlobeNewswire
3/26/2024
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
GlobeNewswire
2/22/2024
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Cl...
GlobeNewswire
2/5/2024
NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer
GlobeNewswire
1/4/2024
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...